Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mar Drugs
2018 Dec 13;1612:. doi: 10.3390/md16120507.
Show Gene links
Show Anatomy links
Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor.
Ning J
,
Li R
,
Ren J
,
Zhangsun D
,
Zhu X
,
Wu Y
,
Luo S
.
???displayArticle.abstract???
Recently, the muscle-type nicotinic acetylcholine receptors (nAChRs) have been pursued as a potential target of several diseases, including myogenic disorders, muscle dystrophies and myasthenia gravis, etc. α-conotoxin GI isolated from Conus geographus selectively and potently inhibited the muscle-type nAChRs which can be developed as a tool to study them. Herein, alanine scanning mutagenesis was used to reveal the structure⁻activity relationship (SAR) between GI and mouse α1β1δε nAChRs. The Pro⁵, Gly⁸, Arg⁸, and Tyr11 were proved to be the critical residues for receptor inhibiting as the alanine (Ala) replacement led to a significant potency loss on mouse α1β1δε nAChR. On the contrary, substituting Asn⁴, His10 and Ser12 with Ala respectively did not affect its activity. Interestingly, the [E1A] GI analogue exhibited a three-fold potency for mouse α1β1δε nAChR, whereas it obviously decreased potency at rat α9α10 nAChR compared to wildtype GI. Molecular dynamic simulations also suggest that loop2 of GI significantly affects the interaction with α1β1δε nAChR, and Tyr11 of GI is a critical residue binding with three hydrophobic amino acids of the δ subunit, including Leu93, Tyr95 and Leu103. Our research elucidates the interaction of GI and mouse α1β1δε nAChR in detail that will help to develop the novel analogues of GI.
81660585 National Natural Science Foundation of China, 31760249 National Natural Science Foundation of China, 81420108028 Major International Joint Research Project of National Natural Science Foundation of China, hdkyx201725 Hainan University Youth foundation, IRT_15R15 Changjiang Scholars and Innovative Research Team in University Grant
Figure 1. Sequences of α-conotoxin GI and its analogues. Each substituted alanine is labeled in bold and blue. The connectivity of Cysteine (CysI-CysIII, CysII-CysIV) is marked in bold and red. * indicates a C-terminal amide.
Figure 2. The HPLC and ESI-MS profiles of α-conotoxin GI and α-conotoxin [E1A] GI. The peptide GI and [E1A] GI were analyzed on a reverse-phase analytical Vydac C18 column with a solvent gradient from 5% buffer B to 40% buffer B for 20 min where buffer A = 0.075% trifluoroacetic acid (TFA), remainder H2O and buffer B = 0.050% TFA, 90% acetonitrile, remainder H2O. The absorbance was monitored at 214 nm. (A) The HPLC chromatogram of fully oxidized peptide GI; (B) ESI-MS data for GI with an observed monoisotopic mass of 1436.50 Da; (C) the HPLC chromatogram of fully folded peptide [E1A] GI; (D) ESI-MS data for [E1A] GI with an observed monoisotopic mass of 1378.52 Da.
Figure 3. The effect on mouse α1β1δε expressed in Xenopus laevis oocytes by GI and alanine-substituted analogues. A bar graph of inhibition of mouse α1β1δε by GI and alanine variants. One-way analysis of variance scatter illustrating the loss or increase in the activity of alanine variants (10 nM) compared to wild peptide using Dunnettâs multiple comparisons test. **** indicates p < 0.0001. All data represent mean ± S.E.M, n = 4â6.
Figure 4. Blockade of mouse α1β1δε nAChR by GI, [E1A] GI and [Y11A] GI. Representative current traces showing the inhibition of mouse α1β1δε ACh-evoked currents by GI and [E1A] GI at the concentration of 10 nM (A, B), GI and [Y11A] GI at the concentration of 10 μM (C, D). Xenopus laevis oocytes expressing a given mouse α1β1δε nAChR were at a holding potential of â70 mV and were subjected to a 1 s pulse of ACh every minute as previously described [30]. After control responses to ACh, the oocyte was exposed to toxins for 5 min (arrow). The toxin was then washed out and the response to ACh was again measured. âCâ indicates control responses to ACh.
Figure 5. The concentrationâresponse curves of mouse α1β1δε nAChR subtype for GI and alanine-substituted analogues. (A) The concentrationâresponse curves for GI and [E1A] GI. peptide [E1A] GI shifted the curves to the left, relative to the parent peptide GI. (B) The concentrationâresponse curves for GI, [P5A] GI, [G8A] GI, [R9A] GI and [Y11A] GI. [P5A] GI, [G8A] GI, [R9A] GI and [Y11A] GI were towards the right compared to the native GI. All data represent mean ± S.E.M, n = 7â10.
Figure 6. The effect of GI and alanine analogues on different nAChR subtypes expressed in Xenopus laevis oocytes. These mutations were determined at the concentration of 10 μM. A bar graph of the inhibition of nAChR subtypes by GI and its analogues. All data represent mean ± S.E.M, n = 4â6.
Figure 7. α-conotoxin GI and its analogues were tested on neuronal rat α9α10 nAChR subtype expressed in Xenopus laevis oocytes. The representative current traces showing the inhibition of rat α9α10 ACh-evoked currents by GI (A), [E1A] GI (B), [P5A] GI (C) and [G8A] GI (D) respectively. Oocytes were clamped at â70 mV holding potential, and membrane currents were evoked with 10 μM ACh. The inhibition of GI, [E1A] GI and [P5A] GI for rat α9α10 nAChR was 48.4%, 10.5%, 72.3% and 69.8% at the concentration of 10 μM respectively. (E) Concentrationâresponse curves for GI, [P5A] GI and [G8A] GI. All data in (E) represent mean ± S.E.M, n = 5â8.
Figure 8. MD stimulations indicate the binding modes of GI to the interface of αδ subunit respectively. (A) Amino acids around 5 à radius of the Glu-1 of GI are labeled. (B) Amino acids around 4 à radius of the Tyr-11 of GI are labeled. The α1(+) subunit is shown in green, δ(â) subunit in cyan and the peptides GI in white.
Akondi,
Discovery, synthesis, and structure-activity relationships of conotoxins.
2014, Pubmed
Akondi,
Discovery, synthesis, and structure-activity relationships of conotoxins.
2014,
Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Azam,
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.
2009,
Pubmed
Benie,
Solution structure of alpha-conotoxin SI.
2000,
Pubmed
Blount,
Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor.
1989,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Bren,
Hydrophobic pairwise interactions stabilize alpha-conotoxin MI in the muscle acetylcholine receptor binding site.
2000,
Pubmed
Ching,
Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis.
2011,
Pubmed
Dao,
Recent Advances in Conotoxin Classification by Using Machine Learning Methods.
2017,
Pubmed
Dutertre,
Toxin insights into nicotinic acetylcholine receptors.
2006,
Pubmed
Eustache,
Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery.
2016,
Pubmed
Gehrmann,
Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability.
1998,
Pubmed
Giribaldi,
Synthesis, Structure and Biological Activity of CIA and CIB, Two α-Conotoxins from the Predation-Evoked Venom of Conus catus.
2018,
Pubmed
Gray,
Peptide toxins from Conus geographus venom.
1981,
Pubmed
Groebe,
Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors.
1997,
Pubmed
Groebe,
alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
1995,
Pubmed
Guddat,
Three-dimensional structure of the alpha-conotoxin GI at 1.2 A resolution.
1996,
Pubmed
Hann,
The 9-arginine residue of alpha-conotoxin GI is responsible for its selective high affinity for the alphagamma agonist site on the electric organ acetylcholine receptor.
1997,
Pubmed
Hann,
The alpha-conotoxins GI and MI distinguish between the nicotinic acetylcholine receptor agonist sites while SI does not.
1994,
Pubmed
Hurst,
Nicotinic acetylcholine receptors: from basic science to therapeutics.
2013,
Pubmed
Jacobsen,
Critical residues influence the affinity and selectivity of alpha-conotoxin MI for nicotinic acetylcholine receptors.
1999,
Pubmed
,
Xenbase
Jiang,
Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor.
2017,
Pubmed
,
Xenbase
Johnson,
alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
1995,
Pubmed
,
Xenbase
Kalamida,
Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.
2007,
Pubmed
Kreienkamp,
Glycosylation sites selectively interfere with alpha-toxin binding to the nicotinic acetylcholine receptor.
1994,
Pubmed
Lebbe,
Conotoxins targeting nicotinic acetylcholine receptors: an overview.
2014,
Pubmed
Lebbe,
Structure-function elucidation of a new α-conotoxin, Lo1a, from Conus longurionis.
2014,
Pubmed
,
Xenbase
Liu,
Two potent alpha3/5 conotoxins from piscivorous Conus achatinus.
2007,
Pubmed
,
Xenbase
Lluisma,
Characterization of a novel psi-conotoxin from Conus parius Reeve.
2008,
Pubmed
,
Xenbase
Loughnan,
Identification of a novel class of nicotinic receptor antagonists: dimeric conotoxins VxXIIA, VxXIIB, and VxXIIC from Conus vexillum.
2006,
Pubmed
Luo,
A novel inhibitor of α9α10 nicotinic acetylcholine receptors from Conus vexillum delineates a new conotoxin superfamily.
2013,
Pubmed
Luo,
Iodo-alpha-conotoxin MI selectively binds the alpha/delta subunit interface of muscle nicotinic acetylcholine receptors.
2004,
Pubmed
,
Xenbase
Luo,
Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase
Luo,
Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
2015,
Pubmed
,
Xenbase
Maslennikov,
Two distinct structures of alpha-conotoxin GI in aqueous solution.
1998,
Pubmed
Mir,
Conotoxins: Structure, Therapeutic Potential and Pharmacological Applications.
2016,
Pubmed
Mitchell,
Three-dimensional solution structure of conotoxin psi-PIIIE, an acetylcholine gated ion channel antagonist.
1998,
Pubmed
Morrison,
Combinatorial alanine-scanning.
2001,
Pubmed
Mott,
Expressing acetylcholine receptors after innervation suppresses spontaneous vesicle release and causes muscle fatigue.
2017,
Pubmed
Muttenthaler,
Structure-activity studies on alpha-conotoxins.
2011,
Pubmed
Myers,
alpha-Conotoxins, small peptide probes of nicotinic acetylcholine receptors.
1991,
Pubmed
Olivera,
Diversity of the neurotoxic Conus peptides: a model for concerted pharmacological discovery.
2007,
Pubmed
Pardi,
Solution structures of alpha-conotoxin G1 determined by two-dimensional NMR spectroscopy.
1989,
Pubmed
Park,
Solution conformation of alpha-conotoxin EI, a neuromuscular toxin specific for the alpha 1/delta subunit interface of torpedo nicotinic acetylcholine receptor.
2001,
Pubmed
Robinson,
Conotoxin gene superfamilies.
2014,
Pubmed
Rogers,
The role of laminins in the organization and function of neuromuscular junctions.
2017,
Pubmed
Saxena,
Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.
2017,
Pubmed
Sine,
Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of alpha-conotoxin M1 selectivity.
1995,
Pubmed
Sugiyama,
Residues at the subunit interfaces of the nicotinic acetylcholine receptor that contribute to alpha-conotoxin M1 binding.
1998,
Pubmed
Teichert,
A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.
2005,
Pubmed
,
Xenbase
Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed
Xu,
Conotoxin αD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors.
2015,
Pubmed